{"database": "lobbying", "table": "lobbying_activities", "rows": [[3801917, "6a7a350a-ea76-409a-9a95-39b5b2e4b3c7", "Q1", "DS2 GROUP, LLC", 400694066, "ROCHE DIAGNOSTICS", 2026, "first_quarter", "HCR", "Ensuring Patient Access to Critical Breakthrough Products Act; HR 5269: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act", "HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2026-04-02T13:46:54-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3801917"], "units": {}, "query_ms": 0.7523649837821722, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}